Maryland Medical Assistance Program - Step Therapy, Fail-First Protocols, and Prior Authorization - Prescription Drugs to Treat Serious Mental Illness
Hearing 2/19 at 1:30 p.m. (House)
Summary
The bill bars Maryland’s Medical Assistance Program from using prior‑authorization or step‑therapy (fail‑first) rules for prescription drugs that treat adults with bipolar disorder, schizophrenia, major depression, PTSD, or medication‑induced movement disorders. It takes effect on July 1 2026 and remains in force for three years. The goal is to speed access to needed mental‑health medications for Medicaid recipients.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 808
3 free questions a day, no accountHearings
- Health — Bill HearingHealth · Feb 19, 2026
History
- Hearing canceled
- Hearing 2/19 at 1:30 p.m.
- Hearing 2/19 at 1:00 p.m.
- First Reading Health
Sponsors
- S. Johnson · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 808 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 808 freeOr ask your AI assistant about HB 808 directly:
Add to Claude, ChatGPT or Cursor